1. A Comprehensive Performance Evaluation of Five Blood Glucose Systems in the Hypo-, Eu-, and Hyperglycemic Range. (November 2016) Authors: Zijlstra, Eric; Heinemann, Lutz; Fischer, Annelie; Kapitza, Christoph Journal: Journal of diabetes science and technology Issue: Volume 10:Number 6(2016:Nov.) Page Start: 1316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A single‐dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US‐ and European‐approved versions of insulin aspart Mix 70/30 and SAR341402 rapid‐acting solution in subjects with type 1 diabetes. Issue 3 (10th December 2020) Authors: Kapitza, Christoph; Nosek, Leszek; Schmider, Wolfgang; Teichert, Lenore; Mukherjee, Bhaswati; Nowotny, Irene Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 3(2021) Page Start: 674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acceptability of Implantable Continuous Glucose Monitoring Sensor. (May 2018) Authors: Barnard, Katharine D.; Kropff, Jort; Choudhary, Pratik; Neupane, Sankalpa; Bain, Stephen C.; Kapitza, Christoph; Forst, Thomas; Link, Manuela; Mdingi, Colleen; DeVries, J. Hans Journal: Journal of diabetes science and technology Issue: Volume 12:Number 3(2018:May) Page Start: 634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment. Issue 5 (21st January 2022) Authors: Meier, Juris J.; Quast, Daniel R.; Nauck, Michael A.; Schenker, Nina; Deacon, Carolyn F.; Holst, Jens J.; Plum‐Mörschel, Leona; Kapitza, Christoph Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 5(2022) Page Start: 806 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed‐ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan‐L trial. Issue 10 (8th June 2017) Authors: Wysham, Carol; Bonadonna, Riccardo C.; Aroda, Vanita R.; Puig Domingo, Manuel; Kapitza, Christoph; Stager, William; Yu, Christine; Niemoeller, Elisabeth; Souhami, Elisabeth; Bergenstal, Richard M. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 10(2017) Page Start: 1408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus. Issue 1 (8th September 2016) Authors: Linnebjerg, Helle; Lam, Eric Chen Quin; Zhang, Xin; Seger, Mary E.; Coutant, David; Chua, Laiyi; Kapitza, Christoph; Heise, Tim Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 1(2017) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes. Issue 4 (17th January 2022) Authors: Meier, Juris J.; Granhall, Charlotte; Hoevelmann, Ulrike; Navarria, Andrea; Plum‐Moerschel, Leona; Ramesh, Chethana; Tannapfel, Andrea; Kapitza, Christoph Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 4(2022) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes. Issue 4 (26th December 2019) Authors: Meier, Juris J.; Menge, Björn A.; Schenker, Nina; Erdmann, Silke; Kahle‐Stephan, Melanie; Schliess, Freimut; Kapitza, Christoph; Nauck, Michael A. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 4(2020) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effects on α‐ and β‐cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study. Issue 4 (10th January 2017) Authors: Forst, Thomas; Falk, Alexander; Andersen, Grit; Fischer, Annelie; Weber, Matthias M.; Voswinkel, Stephan; Heise, Tim; Kapitza, Christoph; Plum‐Mörschel, Leona Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 4(2017) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of Injection Speed, Volume, and Site on Pain Sensation. (January 2018) Authors: Zijlstra, Eric; Jahnke, Johannes; Fischer, Annelie; Kapitza, Christoph; Forst, Thomas Journal: Journal of diabetes science and technology Issue: Volume 12:Number 1(2018:Jan.) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗